Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Cervical Cancer: A Literature Review of Current Evidence

Salsabila Ariefani, Putri Rahmadhanita, Floera Finalita

Abstract


Background: The neutrophil-to-lymphocyte ratio (NLR) is a simple systemic inflammatory marker that reflects the balance between pro-tumor inflammation and anti-tumor immunity. Previous studies have shown that a high pre-treatment NLR is associated with poor survival outcomes and advanced clinical stage in cervical cancer. Objective: This review aims to evaluate the prognostic role of NLR and its impact on patient survival. Methods: A literature search was conducted for studies published between 2021-2026 using the PubMed/ MEDLINE database with predefined inclusion and exclusion criteria. A total of eight relevant articles were included in this review. Results: The included studies consistently demonstrated that a high pre-treatment NLR is an independent predictor of poor survival in patients with cervical cancer. Conclusion: NLR appears to be a promising prognostic biomarker for cervical cancer; however, the lack of standardized cut-off values limits its current clinical application.

Full Text:

PDF

References


1. Seb B, Vida B, Keszthelyi E, et al. The Neutrophil-to-Lymphocyte Ratio ( NLR ) as a Potential Predictor in Conization Outcomes for Cervical Cancer. Published online 2025:1-16.

2. Wu J, Chen M, Liang C, Su W. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer : a meta-analysis and systematic review. 2017;8(8):13400-13412.

3. Zhao M, Gao Z, Wang S, Fu J. Predictive significance of lymphocyte level and neutrophil- ­ lymphocyte ratio values during radiotherapy in cervical cancer treatment. 2023;(June):15820-15830. doi:10.1002/cam4.6221

4. Huang Q, Man Q, Hu J, Yang Y, Zhang Y, Wang W. Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer : A systematic review and meta-analysis of observational studies. 2017;8(10):16755-16764.

5. Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis : an umbrella review of systematic reviews and meta-analyses of observational studies. Published online 2020:1-16.

6. Lee JW, Seol KH. Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer. Published online 2021.

7. Seb B, Tóth Z, Lotti L, et al. Neutrophil / Lymphocyte Ratio ( NLR ) as a Predictive Marker for p16 Positivity and Cervical Cancer Progression : Insights from the SCOPE Study. Published online 2025.

8. Zhuang X, Li Y, Zheng H, Fu L. Evaluating the prognostic relevance of neutrophil-to- lymphocyte ratio in cervical cancer : a systematic review and meta-analysis. 2024;(December). doi:10.3389/fonc.2024.1461175

9. Sinaga RA, Kurniadi A. Neutrophil-lymphocyte Ration Difference in Squamous Cell Carcinoma and Adenocarcinoma of Cervical Cancer Perbedaan Rasio Neutrofil Limfosit pada Kanker Serviks Tipe Karsinoma Sel Skuamosa dan Tipe Adenokarsinoma. Published online 2022:391-396.

10. Xu L, Song J. Elevated neutrophil – lymphocyte ratio can be a biomarker for predicting the development of cervical intraepithelial neoplasia. :1-5.

11. Study AC, Afsar S, Turan G, Guney G, Sahin G, Talmac MA. The Relationship between Furin and Chronic Inflammation in the Progression of Cervical Intraepithelial Neoplasia to Cancer : Published online 2023.

12. Li Y, Wang X, Li Y, et al. The Combined Prognostic Value of 18 F- ­ FDG PET / CT Metabolic Parameters of Immune Organs and Hematological Immune- ­ Related Markers in Patients With Locally Advanced Cervical Cancer. Published online 2025. doi:10.1002/cam4.70650

13. Polho GB, Murazawa LK, Oliveira VV, et al. Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple negative breast cancer treated with neoadjuvant chemotherapy. Published online 2025:1-11.

14. Yu J, Huang L, Dong T, Cao L. Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio. J Obstet Gynaecol (Lahore). 2024;44(1). doi:10.1080/01443615.2024.2361858

15. Teketelew BB, Berta DM, Chane E, et al. Diagnostic accuracy of neutrophil-to- lymphocyte and platelet-to-lymphocyte ratios in differentiating thyroid tumors : A systematic review and meta-analysis. Published online 2025:1-18. doi:10.1371/journal.pone.0322382

16. Seb B. The Lymphocyte-to-Monocyte Ratio ( LMR ) as a Novel Biomarker for Cervical Cancer Risk Stratification in Conization Patients. Published online 2025:1-17.

17. Buonacera A, Stancanelli B, Colaci M. Neutrophil to Lymphocyte Ratio : An Emerging Marker of the Relationships between the Immune System and Diseases. Published online 2022.

18. Maughan TS. The prognostic utility of pre- ­ treatment neutrophil- ­ ratio ( NLR ) in colorectal cancer : A systematic review and meta- ­ analysis. 2021;(June):5983-5997. doi:10.1002/cam4.4143

19. Obeagu EI. Integrating neutrophil-to-lymphocyte ratio into cervical cancer management : implications for prognostic assessment and therapeutic strategies – a narrative review. :7406-7412.




DOI: https://doi.org/10.18860/jim.v10i1.41541

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

EDITORIAL OFFICE
Journal of Islamic Medicine
Faculty of Medicine and Health Sciences
Universitas Islam Negeri Maulana Malik Ibrahim Malang
Jl. Locari, Tlekung, Kec. Junrejo, Kota Batu, Jawa Timur 65151
Email: medicaljournal@uin-malang.ac.id

ISSN: 2550-0074

Journal of Islamic Medicine is licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0)